Ibovespa Slides as Oil Surge Weighs

2026-03-27 14:08 By Isabela Couto 1 min. read

The Ibovespa edged down to trade below 182,500 on Friday as investors remained pessimistic amid ongoing Middle East tensions.

US President Trump's extension of the Iran ultimatum failed to ease oil prices, which rose further, prompting continued inflation concerns and lifting bond yields.

This weighed on banking stocks, with Itaú and Bradesco falling over 1% and Banco do Brasil slumping more than 2%.

The utilities sector also extended losses, with Axia down 1.5%.

Other laggards included WEG and Rede D'Or, both down about 1%.

In contrast, Petrobras (+1%) extended gains on higher oil price.

In other news, Braskem plunged 10.4% after reporting a R$10.28 billion loss for Q4 2025.

Goldman turned cautious on Hapvida (-3.8%), downgrading from Buy to Neutral and lowering its price target.

Azul lost over 5% after posting a R$1.6 billion net loss in Q4 2025.

Meanwhile, Ambev gained 1% following Thursday's announcement of a $1 billion investment in responsible alcohol consumption initiatives.



News Stream
Ibovespa Slides as Oil Surge Weighs
The Ibovespa edged down to trade below 182,500 on Friday as investors remained pessimistic amid ongoing Middle East tensions. US President Trump's extension of the Iran ultimatum failed to ease oil prices, which rose further, prompting continued inflation concerns and lifting bond yields. This weighed on banking stocks, with Itaú and Bradesco falling over 1% and Banco do Brasil slumping more than 2%. The utilities sector also extended losses, with Axia down 1.5%. Other laggards included WEG and Rede D'Or, both down about 1%. In contrast, Petrobras (+1%) extended gains on higher oil price. In other news, Braskem plunged 10.4% after reporting a R$10.28 billion loss for Q4 2025. Goldman turned cautious on Hapvida (-3.8%), downgrading from Buy to Neutral and lowering its price target. Azul lost over 5% after posting a R$1.6 billion net loss in Q4 2025. Meanwhile, Ambev gained 1% following Thursday's announcement of a $1 billion investment in responsible alcohol consumption initiatives.
2026-03-27
Ibovespa Tumbles on Thursday
The Ibovespa fell 1.45% to close at 182,733 on Thursday as higher than expected mid-month inflation and hardening geopolitical tensions intensified risk aversion. Market sentiment soured after the IPCA-15 showed a 0.44% rise in March driven by a 5.94% jump in airfares and persistent pressure in food and personal expenses. These domestic headwinds collided with a 5% surge in Brent crude as President Trump warned Iran to get serious before it is too late which overshadowed previous hopes for a peace deal. The resulting spike in Treasury yields and stagflation fears pressured the broad market with major banks facing heavy selling as Banco do Brasil shed 3.8% and Banco Santander fell 1.8% while Itaúsa and Bradesco lost over 1%. Utilities and consumer leaders also struggled with Sabesp dropping 2.7% and Natura sliding 5.1%. Conversely Petrobras gained 2.4% as elevated oil prices supported energy producers while Americanas surged 15.3% following judicial recovery developments.
2026-03-26
Ibovespa Slips on Inflation Surprise and Middle East War Uncertainty
The Ibovespa lost about 0.5% to trade below 185,000 on Thursday, pressured by higher-than-expected mid-month inflation and mixed Middle East war signals. The IPCA-15's momentum slowed in March after seasonal back-to-school effects faded, but food and personal expenses kept inflation above expectations. While the 12-month rate eased, it remains above the 3.0% target, adding pressure on the base rate outlook while Iran conflict-driven oil rises with no clear end in sight could further complicate central banks' rate decisions. Major banks posted losses: Itaú down 1%, Bradesco 0.6%. Utilities traded negative, with Axia and Sabesp shedding over 1%. Other laggards included Vale down 0.6%, WEG down 0.6%, and Ambev down 0.5%. Petrobras gained near 1% on higher oil prices. Americanas surged near 17% after filing to exit judicial recovery, selling assets, and reporting sharp Q4 2025 improvement versus Q4 2024.
2026-03-26